Publications by authors named "Rachael Anforth"

Claim this Profile
I
Investigating the impact of exercise on T and NK cells in skin cancer: a systematic review.
Heidi F Bochenek, David B Pyne, Andrew J McKune, Rachel E Neale, Rachael M Anforth

Exerc Immunol Rev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
Cathy Yunjia Zhao, Shelley Ji Eun Hwang, Rachael Anforth, Giuliana Carlos, Shaun Chou

J Immunother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study.
Cathy Yunjia Zhao, Shelley Ji Eun Hwang, Deepal Wakade, Giuliana Carlos, Rachael Anforth

Australas J Dermatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of BRAFi-induced hyperproliferative cutaneous conditions.
Marina Ali, Rachael Anforth, Flavia Senetiner, Giuliana Carlos, Pablo Fernandez-Penas

Exp Dermatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.
Giuliana Carlos, Rachael Anforth, Arthur Clements, Alexander M Menzies, Matteo S Carlino

JAMA Dermatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tinea hidden by a vemurafenib-induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone.
Rachael Anforth, Giuliana Carlos, Noemi Eiris, Arthur Clements, Pablo Fernandez-Peñas

Med J Aust· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Giuliana Carlos, Rachael Anforth, Shaun Chou, Arthur Clements, Pablo Fernandez-Peñas

Melanoma Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy.
Rachael Anforth, Alexander Menzies, Karen Byth, Giuliana Carlos, Shaun Chou

J Am Acad Dermatol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma.
Rachael M Anforth, Giuliana R M Carlos, Richard A Scolyer, Shaun Chou, Pablo Fernandez-Peñas

Melanoma Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.
Rachael Anforth, Michael Liu, Bao Nguyen, Pablo Uribe, Richard Kefford

Australas J Dermatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib-associated necrobiotic granulomatous reaction.
Giuliana Carlos, Rachael Anforth, Shaun Chou, Pablo Fernandez-Peñas

Australas J Dermatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy.
Pablo Uribe, Rachael M Anforth, Richard F Kefford, Pablo Fernandez-Peñas

Melanoma Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panniculitis in patients treated with BRAF inhibitors: a case series.
Bonita Choy, Shaun Chou, Rachael Anforth, Pablo Fernández-Peñas

Am J Dermatopathol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibitor induced verrucal keratosis.
Rachael Anforth, Pablo Fernandez-Penas

Am J Dermatopathol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous toxicities of RAF inhibitors.
Rachael Anforth, Pablo Fernandez-Peñas, Georgina V Long

Lancet Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors.
Rachael Anforth, Varsha Tembe, Tatiana Blumetti, Pablo Fernandez-Peñas

Pigment Cell Melanoma Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Rachael Anforth, Tatiana Cristina Moraes Pinto Blumetti, Azura Mohd Affandi, Pablo Fernandez-Penas

J Clin Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis